A 2-year prospective surveillance of pediatric traumatic optic neuropathy in the United Kingdom.
BACKGROUND
To report epidemiologic data on traumatic optic neuropathy (TON) in patients less than 18 years of age in the United Kingdom acquired by prospective population-based active surveillance through the British Ophthalmic Surveillance Unit.


METHODS
Data were obtained from incident and 6-month follow-up questionnaires sent to reporting ophthalmologists over a period of 2 years. Main outcome measures were demographic data, clinical and visual function at presentation and follow-up, investigations, and treatments used.


RESULTS
A total of 26 cases (21 males) were identified; follow-up data were available for 23 (88%). Minimum estimated annual incidence was 0.99 cases per million. Leading causes of TON included 6 sports injuries (23%), 5 falls (19%), and 4 traffic accidents (16%). Presenting best-corrected visual acuity was ≤ 6/60 in 15 cases (58%), with no light perception in 7 cases (27%). Associated injuries were as follows: nonpenetrating injuries, 8 (31%); adnexal injuries, 3 (11.5%); orbital fractures, 5 (19%); skull fractures, 3 (12%); intracranial bleeding, 1 (4%). Fourteen (54%) received no treatment, and 9 (35%) were treated with steroids. Final visual acuity improved in 7 of 21 patients (33%), with 13 of 23 (56%) achieving final visual acuity ≤ 6/60, 10 of whom (43%) had no light perception. Baseline visual acuity was associated with last follow-up visual acuity (P = 0.03), but treatment and improvement of visual acuity by at least 3 lines were not associated. Treatment was more common in children with poor presenting vision (P = 0.03).


CONCLUSIONS
The incidence, natural history, poor presenting visual acuity, and male prevalence of TON in children appear similar to adults in adults in the UK.
Central Eye Service, Central Middlesex Hospital, North West London NHS Trust, London, United Kingdom.
Rebecca L
RL
Ford
Vickie
V
Lee
Wen
W
Xing
Catey
C
Bunce
D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D020221:Optic Nerve Injuries / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D011446:Prospective Studies; D012737:Sex Factors; D013256:Steroids / Q000627:therapeutic use; D006113:United Kingdom / Q000453:epidemiology; D014792:Visual Acuity / Q000502:physiology
D013256:Steroids